Results 191 to 200 of about 29,994,236 (203)
Some of the next articles are maybe not open access.

Bioactive Compounds from Euphorbia usambarica Pax. with HIV-1 Latency Reversal Activity

Pharmaceuticals, 2021
Racheal A Nell   +2 more
exaly  

Investigating the ubiquitin-proteasome system for targeted reversal of HIV-1 latency

2018
HIV is a worldwide epidemic, remaining the ever-present specter among all matters regarding blood or other bodily fluids, such as sexual intercourse, healthcare, blood transfusions, or even surgery, particularly in resource-poor areas. While antiretroviral drug therapy is highly successful in suppressing the virus and preventing transmission, it cannot
openaire   +1 more source

HIV latency reversal agents: A potential path for functional cure?

European Journal of Medicinal Chemistry, 2021
Jean Leandro Dos Santos   +2 more
exaly  

Isoform-Selective Versus Nonselective Histone Deacetylase Inhibitors in HIV Latency Reversal

AIDS Research and Human Retroviruses, 2022
George B Kyei, Anthony Twumasi Boateng
exaly  

Potentiation of Drug Toxicity through Virus Latency Reversal Promotes Preferential Elimination of HIV Infected Cells

Advanced Therapeutics, 2022
Alexander N. Zelikin   +2 more
exaly  

Tracking HIV Rebound following Latency Reversal Using Barcoded HIV

Cell Reports Medicine, 2020
Jerome A Zack   +2 more
exaly  

Type 1-programmed dendritic cells drive antigen-specific latency reversal and immune elimination of persistent HIV-1

EBioMedicine, 2019
Robbie B. Mailliard   +2 more
exaly  

Home - About - Disclaimer - Privacy